What is it about?
This study investigates how malaria parasites evolve resistance to chloroquine, an important antimalarial drug. The researchers genetically engineered malaria parasites to have different combinations of mutations in the pfcrt gene, which is associated with chloroquine resistance. They then measured how these mutations affect the parasites' drug resistance and growth. Using this data, they ran computer simulations to model the most likely evolutionary pathways that lead to chloroquine resistance. The results suggest that resistance likely evolved through rare events where parasites acquired multiple mutations simultaneously, rather than accumulating single mutations over time. The study also found that some mutations increase resistance but decrease parasite growth, highlighting trade-offs in the evolution of resistance.
Featured Image
Photo by digitale.de on Unsplash
Why is it important?
This study is crucial for combating one of the world's deadliest diseases. By unraveling how malaria parasites evolve drug resistance, it provides vital insights that could help preserve the effectiveness of current treatments and guide the development of new ones. The research reveals the complex interplay between mutations that confer resistance and those that maintain parasite fitness, showing why some resistant strains persist while others fade away. Understanding these evolutionary pathways is key to predicting and potentially preventing the spread of resistance.
Perspectives
Read the Original
This page is a summary of: Combinatorial Genetic Modeling ofpfcrt-Mediated Drug Resistance Evolution inPlasmodium falciparum, Molecular Biology and Evolution, February 2016, Oxford University Press (OUP),
DOI: 10.1093/molbev/msw037.
You can read the full text:
Contributors
The following have contributed to this page